Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Ratcliffe Liam
Relationship:   Director
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   14    
Direct Shares   5,450,392    

Indirect Shares

   11,059,115      
Direct Value   $32,791,673    

Indirect Value

   $72,584,031      
Total Shares   16,509,507      
Total Value   $105,375,705      


Oxford Immunotec Global Plc $30,291,159 Concert Pharmaceuticals, Inc. $898,327 Chimerix Inc $1,496,784 Aravive Inc $96,616 PDS Biotechnology Corp $5,036 Passage Bio, Inc. $3,752 Oxford Immunotec Global Plc $30,291,159 Concert Pharmaceuticals, Inc. $898,327 Chimerix Inc $1,496,784 Aravive Inc $96,616 PDS Biotechnology Corp $5,036 Passage Bio, Inc. $3,752
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    2   
    11    

     Stock price went up :
    1   
    0    
     Stock price went down :
    1   
    11    
   
     Gain/Loss Ratio :
   0.0   
   -11.0   
     Percentage Gain/Loss :
   11.6%
 -418.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Relypsa Inc RLYP Former 10% beneficial ... 2013-11-20 0 2013-11-20 2,114,890    Premium*  
            Oxford Immunotec Global Plc OXFD 10% Owner 2013-11-21 1,377,497 0    Premium*  
            MEI Pharma Inc MEIP 10% Owner 2015-03-24 0 2013-11-21 0    Premium*  
            Concert Pharmaceuticals, Inc. CNCE 10% Owner 2014-02-19 107,327 0    Premium*  
            Chimerix Inc CMRX 10% Owner 2014-03-18 1,543,394 2014-03-18 0    Premium*  
            Aravive Inc ARAV 10% Owner 2014-12-18 2,409,374 2014-03-27 0    Premium*  
            Durata Therapeutics, Inc. DRTX 10% Owner 2014-11-17 0 2014-11-17 0    Premium*  
            Cogent Biosciences, Inc. COGT Director 2018-04-03 0 2018-04-03 897,773    Premium*  
            Deciphera Pharmaceuticals, Inc. DCPH Director, 10% Owner 2017-10-02 0 2017-10-02 2,146,308    Premium*  
            Iterum Therapeutics Plc ITRM 10% Owner 2018-05-30 0 2018-05-30 384,615    Premium*  
            Aptinyx Inc. APTX Director, 10% Owner 2018-06-25 0 2018-06-25 368,345    Premium*  
            Arvinas Holding Company, Llc ARVN Director 2021-11-05 0 2021-12-16 185,686    Premium*  
            PDS Biotechnology Corp PDSB Director 2019-03-15 10,000 2019-03-15 2,344,868    Premium*  
            Passage Bio, Inc. PASG Director 2020-03-03 2,800 2020-03-03 2,616,630    Premium*  
* Premium Members only  

Records found :    47         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 2
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
OXFD Oxford Immunotec Global P... 10% Owner   –       –       •   2013-11-21 3 IO $0.00 $0 D/D 0 1,377,497 -
CNCE Concert Pharmaceuticals, ... 10% Owner   –       –       •   2014-02-12 3 IO $0.00 $0 D/D 0 15,291 -
PASG Passage Bio, Inc. Director   –       •      –    2020-03-03 4 B $18.00 $50,400 D/D 2,800 2,800 2.39 %
ARVN Arvinas Holding Company, ... Director   –       •      –    2020-05-26 4 OE $22.06 $143,390 D/D 6,500 6,500 0 -
MEIP MEI Pharma Inc 10% Owner   –       –       •   2014-12-08 4 S $6.05 $54,495 D/D (9,004) 1,671,471 0 -
PDSB PDS Biotechnology Corp Director   •       •      –    2019-03-15 4 OE $0.00 $0 D/D 10,000 10,000 0 -
ARAV Aravive Inc 10% Owner   –       –       •   2014-09-29 4 S $20.02 $251,331 D/D (12,556) 3,359,374 0 -
ARVN Arvinas Holding Company, ... Director   –       •      –    2021-11-10 4 S $86.59 $1,178,188 I/I (13,358) 662,343 0 %
ARVN Arvinas Holding Company, ... Director   –       •      –    2021-11-05 4 OE $22.06 $544,531 D/D 18,423 24,923 0 -
ARVN Arvinas Holding Company, ... Director   –       •      –    2021-11-15 4 S $83.90 $1,806,469 I/I (21,284) 541,391 0 %
RLYP Relypsa Inc Former 10% beneficial owner   –       –      –    2013-11-20 4 D $11.00 $238,601 I/I (21,691) 1,928,912 0 -
ARVN Arvinas Holding Company, ... Director   –       •      –    2021-11-05 4 S $89.65 $2,275,362 D/D (24,923) 0 0 %
RLYP Relypsa Inc Former 10% beneficial owner   –       –      –    2013-11-20 4 OE $9.18 $238,594 I/I 25,977 1,950,603 0 -
ARVN Arvinas Holding Company, ... Director   –       •      –    2021-11-09 4 S $91.33 $3,035,861 I/I (33,008) 675,701 0 %
ARVN Arvinas Holding Company, ... Director   –       •      –    2021-11-05 4 S $89.86 $3,039,319 I/I (33,094) 789,763 0 %
ARVN Arvinas Holding Company, ... Director   –       •      –    2021-11-12 4 S $84.02 $3,386,461 I/I (39,869) 562,675 0 %
ARVN Arvinas Holding Company, ... Director   –       •      –    2021-11-11 4 S $85.92 $5,156,393 I/I (59,799) 602,544 0 %
ARAV Aravive Inc 10% Owner   –       –       •   2014-03-27 4 B $21.02 $1,261,200 D/D 60,000 3,371,930 2.45 -
MEIP MEI Pharma Inc 10% Owner   –       –       •   2014-12-09 4 S $6.01 $421,082 D/D (70,081) 1,601,390 0 -
ARVN Arvinas Holding Company, ... Director   –       •      –    2021-11-08 4 S $92.48 $7,655,882 I/I (81,054) 708,709 0 %
ARVN Arvinas Holding Company, ... Director   –       •      –    2021-12-16 4 S $68.97 $5,944,418 I/I (85,705) 185,686 0 %
CNCE Concert Pharmaceuticals, ... 10% Owner   –       –       •   2014-02-19 4 A $0.00 $0 D/D 92,036 107,327 0 -
ARVN Arvinas Holding Company, ... Director   –       •      –    2021-12-15 4 S $65.74 $7,584,964 I/I (113,536) 271,391 0 %
ARVN Arvinas Holding Company, ... Director   –       •      –    2020-12-18 4 B $70.00 $9,999,990 I/I 142,857 822,857 2.1 %
ARAV Aravive Inc 10% Owner   –       –       •   2014-12-18 4 S $19.01 $2,851,845 D/D (150,000) 2,409,374 0 -
  47  Records found
  1  2      
  Page 1 of 2  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us